Recent Posts
- Optimind Acquires MindSetting Institute to Integrate Three-Pronged Approach to its Business and Become Industry Leader in Psychedelic Enhanced Psychotherapy
- Optimind Provides Update on Health Canada’s Dealer License under Joint-Venture with Manitari Pharma
- Optimind Pharma Commences Trading on the CSE Under Ticker Symbol OMND
- Optimind Pharma Announces Closing of Reverse Takeover Transaction
Recent Comments